{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:04:23Z","timestamp":1793131463474,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.radonc.2017.10.001","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T19:45:35Z","timestamp":1508183135000},"page":"293-300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer"],"prefix":"10.1016","volume":"125","author":[{"given":"Kyle","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.","family":"Patchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison M.","family":"Deal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panayiotis","family":"Mavroidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Lipner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Zagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie B.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Eblan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian G.","family":"Rosenman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Socinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Stinchcombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence B.","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2017.10.001_b0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<265::AID-CNCR10>3.0.CO;2-B","article-title":"A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinoma. Groupe d'Etude et de Traitement des Cancers Bronchiques","volume":"86","author":"Dautzenberg","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.10.001_b0010","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/cncr.22845","article-title":"The risk of death from heart disease in patients with nonsmall cell lung cancer who receive postoperative radiotherapy: analysis of the Surveillance, Epidemiology, and End Results database","volume":"110","author":"Lally","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.10.001_b0015","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijrobp.2008.01.044","volume":"72","author":"Douillard","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0025","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.radonc.2016.04.025","article-title":"Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation","volume":"119","author":"Tucker","year":"2016","journal-title":"Radiother Oncol"},{"issue":"13","key":"10.1016\/j.radonc.2017.10.001_b0035","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: pooled analysis of dose-escalation trials delivering 70 to 90 Gy","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.radonc.2017.10.001_b0040","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","article-title":"Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients","volume":"123","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0045","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/j.ijrobp.2016.06.128","article-title":"Data mining identifies the base of the heart as a dose-sensitive region affecting survival in lung cancer patients","volume":"96","author":"McWilliam","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0050","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","author":"van den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0055","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/1097-0142(20010901)92:5<1213::AID-CNCR1440>3.0.CO;2-0","article-title":"Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin\/paclitaxel in unresectable stage IIIA\/B nonsmall cell lung carcinoma: a modified phase I\/II trial","volume":"92","author":"Socinski","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.10.001_b0060","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1200\/JCO.2004.02.165","article-title":"Carboplatin\/paclitaxel or carboplatin\/vinorelbine followed by accelerated hyperfractionated conformal radiation therapy: report of a prospective phase I dose escalation trial from the Carolina Conformal Therapy Consortium","volume":"22","author":"Marks","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0065","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1200\/JCO.2004.03.022","article-title":"Induction and concurrent chemotherapy with high-dose thoracic conformal radiation therapy in unresectable stage IIIA and IIIB non-small-cell lung cancer: a dose-escalation phase I trial","volume":"22","author":"Socinski","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0070","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1200\/JCO.2007.14.7371","article-title":"Randomized phase II trial of induction chemotherapy followed by concurrent chemotherapy and dose-escalated thoracic conformal radiotherapy (74 Gy) in stage III non-small-cell lung cancer: CALGB 30105","volume":"26","author":"Socinski","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/JTO.0b013e3181653cf4","volume":"3","author":"Stinchcombe","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0080","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1200\/JCO.2012.41.9820","article-title":"Incorporating bevacizumab and erlotinib in the combined-modality treatment of stage III non-small-cell lung cancer: results of a phase I\/II trial","volume":"30","author":"Socinski","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0085","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ijrobp.2009.10.058","article-title":"Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer","volume":"79","author":"Feng","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0090","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1097\/HJH.0b013e3282861fd3","article-title":"World Health Organization (WHO) and International Society of Hypertension (ISH) risk prediction charts: assessment of cardiovascular risk for prevention and control of cardiovascular disease in low and middle-income countries","volume":"25","author":"Mendis","year":"2007","journal-title":"J Hypertens."},{"key":"10.1016\/j.radonc.2017.10.001_b0095","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.radonc.2017.10.001_b0100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1158\/1078-0432.CCR-06-1210","article-title":"Cumulative incidence in competing risks data and competing risks regression analysis","volume":"13","author":"Kim","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2017.10.001_b0105","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med."},{"key":"10.1016\/j.radonc.2017.10.001_b0110","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1200\/JCO.2015.63.4444","article-title":"Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma","volume":"34","author":"van Nimwegen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0115","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2017.10.001_b0120","doi-asserted-by":"crossref","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","article-title":"Cardiovascular disease after treatment for Hodgkin's lymphoma: an analysis of nine collaborative EORTC-LYSA trials","volume":"2","author":"Maraldo","year":"2015","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.radonc.2017.10.001_b0125","unstructured":"NCI. Common Terminology Criteria for Adverse Events v4.0 NIH publication # 09-7473; 2009."},{"key":"10.1016\/j.radonc.2017.10.001_b0130","unstructured":"RTOG. RTOG\/EORTC Late Radiation Morbidity Scoring Schema. https:\/\/www.rtog.org\/ResearchAssociates\/AdverseEventReporting\/RTOGEORTCLateRadiationMorbidityScoringSchema.aspx. Accessed 1\/30\/2017."},{"key":"10.1016\/j.radonc.2017.10.001_b0135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3389\/fonc.2015.00039","article-title":"Radiation-induced heart disease: pathologic abnormalities and putative mechanisms","volume":"5","author":"Taunk","year":"2015","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0140","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0046-8177(96)90447-5","article-title":"Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases","volume":"27","author":"Veinot","year":"1996","journal-title":"Hum Pathol."},{"key":"10.1016\/j.radonc.2017.10.001_b0145","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/0967-2109(96)82320-9","article-title":"Changes in the proportion of types I and III collagen in the left ventricular wall of patients with post-irradiative pericarditis","volume":"4","author":"Chello","year":"1996","journal-title":"Cardiovasc Surg."},{"key":"10.1016\/j.radonc.2017.10.001_b0150","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.radonc.2015.07.029","article-title":"Late proliferating and inflammatory effects on murine microvascular heart and lung endothelial cells after irradiation","volume":"117","author":"Sievert","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0155","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/1097-0142(197606)37:6<2813::AID-CNCR2820370637>3.0.CO;2-S","article-title":"Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications","volume":"37","author":"Carmel","year":"1976","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.10.001_b0160","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0360-3016(97)00584-1","article-title":"Fraction size and dose parameters related to the incidence of pericardial effusions","volume":"40","author":"Martel","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0165","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ijrobp.2007.10.056","article-title":"Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy","volume":"70","author":"Wei","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0170","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(02)00133-0","article-title":"Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy","volume":"64","author":"Seddon","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0175","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijrobp.2005.01.029","article-title":"The incidence and functional consequences of RT-associated cardiac perfusion defects","volume":"63","author":"Marks","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2017.10.001_b0185","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.radonc.2015.04.009","article-title":"Early detection of radiation-induced heart disease using (99m)Tc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy","volume":"115","author":"Zhang","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0190","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13014-015-0436-2","article-title":"Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy","volume":"10","author":"Skytta","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0195","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3109\/09553002.2015.1027421","article-title":"Kinetics of B-type natriuretic peptide plasma levels in patients with left-sided breast cancer treated with radiation therapy: Results after one-year follow-up","volume":"91","author":"D'Errico","year":"2015","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2017.10.001_b0200","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/1097-0142(19860301)57:5<929::AID-CNCR2820570509>3.0.CO;2-6","article-title":"Incidence of heart disease and functional significance of changes in the electrocardiogram 10 years after radiotherapy for breast cancer","volume":"57","author":"Strender","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2017.10.001_b0205","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.radonc.2016.08.024","article-title":"Risk of pacemaker or implantable cardioverter defibrillator after radiotherapy for early-stage breast cancer in Denmark, 1982\u20132005","volume":"122","author":"Rehammar","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0210","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1097\/JTO.0000000000000306","article-title":"Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure","volume":"9","author":"Gomez","year":"2014","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0215","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non-small cell lung cancer","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0220","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/jamaoncol.2015.3969","article-title":"Quality of life analysis of a radiation dose-escalation study of patients with non-small-cell lung cancer: A secondary analysis of the radiation therapy oncology Group 0617 randomized clinical trial","volume":"2","author":"Movsas","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2017.10.001_b0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: a secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017326294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814017326294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T17:33:37Z","timestamp":1535304817000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814017326294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S0167814017326294"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2017.10.001","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for Stage III non-small-cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2017.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}